Which of the following parameters is not used for risk assessment and need to sta anticoagulation in a patient of atrial fibrillation?
**Core Concept**
Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of thromboembolic events, particularly stroke. The CHA2DS2-VASc score is a widely used risk assessment tool to predict the risk of stroke in patients with non-valvular AF, guiding the decision for anticoagulation therapy. The score incorporates various clinical parameters to estimate the risk of stroke, including congestive heart failure, hypertension, age, diabetes mellitus, stroke or transient ischemic attack (TIA), vascular disease, age ≥ 75 years, and sex category.
**Why the Correct Answer is Right**
The CHA2DS2-VASc score is a well-established and validated tool for predicting stroke risk in patients with AF. It takes into account the presence of several clinical factors, including hypertension, age, diabetes mellitus, vascular disease, and a history of stroke or TIA. The score is calculated by assigning points for each of these factors, with a higher score indicating a greater risk of stroke. The presence of two or more factors (CHA2DS2-VASc ≥ 2) is generally considered a threshold for initiating anticoagulation therapy in patients with AF. By using the CHA2DS2-VASc score, clinicians can accurately assess the risk of stroke and make informed decisions about anticoagulation therapy.
**Why Each Wrong Option is Incorrect**
* **Option A:** is not a parameter used in the CHA2DS2-VASc score, which focuses on clinical factors rather than laboratory values.
* **Option B:** is a component of the CHA2DS2-VASc score, indicating a history of stroke or TIA.
* **Option C:** is also a component of the CHA2DS2-VASc score, indicating the presence of vascular disease.
* **Option D:** is a component of the CHA2DS2-VASc score, indicating a history of diabetes mellitus.
**Clinical Pearl / High-Yield Fact**
When assessing a patient with atrial fibrillation for the need to start anticoagulation therapy, keep in mind that a CHA2DS2-VASc score of 2 or greater is generally considered a threshold for initiating anticoagulation. This score takes into account various clinical factors, including hypertension, age, diabetes mellitus, vascular disease, and a history of stroke or TIA.
**Correct Answer:** D.